Your session is about to expire
← Back to Search
Kisspeptin-10 for Metabolic Diseases
This trial looks at how the hormone kisspeptin affects metabolism and blood sugar levels.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a Location
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
- You have gone through puberty normally.You have a normal menstrual cycle.You have a healthy weight for your height.You currently use illegal drugs.You have had a serious reaction to a medication in the past that required urgent medical attention.A close family member, like your parent or sibling, has diabetes.You have a history of high blood pressure, diabetes, heart disease, high cholesterol, cancer, or clotting disorders.
- Group 1: Kisspeptin
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are engaged in this research endeavor?
"Affirmative, the clinical trial is still open for recruitment. According to data available on clinicaltrials.gov, this study was first published on June 3rd 2022 and its details were last modified on July 12th 2022. This research has a requirement of 12 participants from one site."
How has Hyperglycemic Clamp been assessed for its safety in human patients?
"Hyperglycemic Clamp is a relatively untested therapeutic intervention, so it only received a score of 1 due to the lack of data regarding its efficacy and safety."
Does the criteria for this research encompass participants over 50 years of age?
"This clinical trial is open to individuals between 18 and 40 years of age. There are separate trials for those under the legal voting age as well as one specifically tailored towards seniors above 65."
Who is eligible to become a participant of this research?
"Eligible participants in this trial must be under 40 years of age and suffering from a metabolic disorder. Additional requirements include being 17 or older, normal pubertal development, regular menstrual cycles, stable weight within the last three months, BMI below average values for their height and sex (systolic BP < 140 mm Hg/diastolic < 90 mm Hg), hemoglobin level within the physiological range (A1C < 6.5%), creatinine not elevated above baseline levels as well as AST & ALT concentrations lower than 3 times upper limit of normative figures."
Does this research project currently have open enrollment?
"Indeed, the information on clinicaltrials.gov reveals that this research is currently enrolling patients. Initially posted on June 3rd 2022 and last modified on July 12th 2022, it seeks to recruit a total of twelve participants from one location."
Share this study with friends